QA: OMEROS CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2023_OMEROS_CORP.pdf

Logs

Graph

Absolute values for 0001285819, OMEROS CORP

  xvar xval
0 AssetsCurrent 443,236,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 147,733,000
4 LiabilitiesCurrent 136,383,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 50,668,000
9 ResearchAndDevelopmentExpense 112,721,000
10 remainder_Expenses 22,702,000
11 remainder_Revenues 4,062,000
12 remainder_NetIncome 229,446,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 590,969,000
1 Liabilities 136,383,000
2 Expenses 186,091,000
3 Revenues 4,062,000
4 StockholdersEquity 454,586,000
5 NetIncome 47,417,000
6 ComprehensiveNetIncome 47,417,000
7 BaseVar 573,475,500
8 EconomicCapitalRatio 2.28

Edgar->Model Mapping

Feature Distribution

Change over Time